Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

flibanserin Oral Tablet [Addyi]

National Institutes of Health

Related topics

Related topics

3 relations
AddyiOral Tablet

Narrower (1)

flibanserin 100 MG Oral Tablet [Addyi]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Development and Syntheses of Flibanserin (Addyi®) - "the Female Viagra®"
In 2015, the drug Addyi® (flibanserin) was launched, the first drug to treatment of Female Sexual Interest/Arousal Disorder… 
Review
2015
Review
2015
The Female Sexual Response: Current Models, Neurobiological Underpinnings and Agents Currently Approved or Under Investigation for the Treatment of Hypoactive Sexual Desire Disorder
How a woman responds to sexual cues is highly dependent on a number of distinct, yet related, factors. Researchers have attempted… 
  • figure 1
  • figure 2
  • figure 3
  • table 1
Review
2015
Review
2015
Flibanserin: First Global Approval
Flibanserin (Addyi™) is chemically described as a benzimidazole and is being developed by Sprout Pharmaceuticals for the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE